IMMUNE SYSTEM KEY LTD has a total of 29 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2005. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are MOLECULAR SKINCARE LTD, SYGNIS BIOSCIENCE GMBH & CO KG and LANG FLORIAN.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Australia | 3 | |
#3 | Canada | 3 | |
#4 | China | 3 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | Israel | 3 | |
#7 | Republic of Korea | 3 | |
#8 | United States | 3 | |
#9 | Singapore | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Devary Yoram | 25 |
#2 | Sandler Uziel | 25 |
#3 | Yoram Devary | 1 |
#4 | Uziel Sandler | 1 |
Publication | Filing date | Title |
---|---|---|
KR20180104083A | Cancer Therapy for the Treatment of Cancer and ER Stress as a Prediction Tool in Combination Therapy | |
CN105939724A | Pharmaceutical compositions and methods for the treatment and prevention of metastatic cancer | |
US2010204097A1 | Therapeutic methods using a thymus peptide | |
WO2007122622A1 | Method of treatment of a disease | |
WO2007091240A2 | Treatment of immunological diseases | |
WO2006046239A2 | A thymus-specific protein |